Home/Pipeline/Branded MENA Portfolio

Branded MENA Portfolio

Chronic Diseases (Diabetes, Respiratory, Cardiology)

Approved/RegistrationCommercial

Key Facts

Indication
Chronic Diseases (Diabetes, Respiratory, Cardiology)
Phase
Approved/Registration
Status
Commercial
Company

About Hikma Pharmaceuticals

Hikma Pharmaceuticals is a UK-based, publicly traded global pharmaceutical company with a mission to put better health within reach, every day. It has established itself as a leader in injectable medicines and maintains a significant portfolio of generic and branded products across therapeutic areas including oncology, cardiovascular, CNS, and anti-infectives. The company's strategic direction focuses on organic growth, strategic acquisitions, and expanding its presence in key emerging markets, particularly in the MENA region where it has a strong heritage and market leadership.

View full company profile